; (D) promote investments in community-based activities that empower women, support voluntarism, and provide respectful maternity care; (E) describe how the most vulnerable populations in each priority country will be targeted and reached with highest-impact, evidence-based interventions to reduce maternal, newborn, and child mortality; (F) use United States Government strategies and frameworks relevant to improving maternal, newborn, and child health; (G) address backsliding on access to and demand for essential health services and other key challenges affecting maternal, newborn, and child survival caused by the COVID–19 pandemic; (H) include development and scale-up of new technologies and approaches, including those supported by public-private partnerships, for research and innovation; (I) promote coordination and efficiency within and among the relevant executive branch agencies and initiatives, including the United States Agency for International Development, the Department of State, the Department of Health and Human Services, the Centers for Disease Control and Prevention, the National Institutes of Health, the Millennium Challenge Corporation, the Peace Corps, the Department of the Treasury, the Office of the Global AIDS Coordinator, the President’s Malaria Initiative, and the United States International Development Finance Corporation; (J) project general levels of resources needed to achieve the objectives stated in the strategy; and (K) support the transition to domestic sustainably financed health systems, emphasizing partnerships that seek to ensure affordability, accessibility, quality, and delivery of health services in an equitable and sustainable manner. (4) Development of strategy (A) Consultation by Administrator The Administrator shall consult with missions of the United States Agency for International Development in priority countries, civil society, and implementing partner organizations to inform the development of the strategy. (B) Local consultation